JP2004535795A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004535795A5 JP2004535795A5 JP2002589630A JP2002589630A JP2004535795A5 JP 2004535795 A5 JP2004535795 A5 JP 2004535795A5 JP 2002589630 A JP2002589630 A JP 2002589630A JP 2002589630 A JP2002589630 A JP 2002589630A JP 2004535795 A5 JP2004535795 A5 JP 2004535795A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- nucleic acid
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29023901P | 2001-05-10 | 2001-05-10 | |
| PCT/US2002/014587 WO2002092762A2 (en) | 2001-05-10 | 2002-05-08 | Cytokine polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004535795A JP2004535795A (ja) | 2004-12-02 |
| JP2004535795A5 true JP2004535795A5 (https=) | 2005-12-22 |
Family
ID=23115104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002589630A Withdrawn JP2004535795A (ja) | 2001-05-10 | 2002-05-08 | サイトカインポリペプチド群 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20030104579A1 (https=) |
| EP (1) | EP1412499A4 (https=) |
| JP (1) | JP2004535795A (https=) |
| AU (1) | AU2002314774B2 (https=) |
| CA (1) | CA2446180A1 (https=) |
| MX (1) | MXPA03010181A (https=) |
| PL (1) | PL373008A1 (https=) |
| WO (1) | WO2002092762A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60135393D1 (de) | 2000-06-30 | 2008-09-25 | Zymogenetics Inc | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 |
| US7038032B2 (en) | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| US7910313B2 (en) | 2001-04-20 | 2011-03-22 | Zymogenetics, Inc. | Cytokine protein family |
| EP1942187B1 (en) * | 2001-04-20 | 2010-09-22 | ZymoGenetics, L.L.C. | Cytokine protein family |
| WO2003066002A2 (en) | 2002-02-08 | 2003-08-14 | University Of Medicine And Dentistry Of New Jersey | IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION |
| CA2503305A1 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| EP2251352A1 (en) * | 2003-08-07 | 2010-11-17 | ZymoGenetics, L.L.C. | Homogeneous preparations of IL-28 and IL-29 |
| JP4896005B2 (ja) | 2004-04-02 | 2012-03-14 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
| JP2008508310A (ja) | 2004-07-29 | 2008-03-21 | ザイモジェネティクス， インコーポレイテッド | がんおよび自己免疫障害を治療するためのｉｌ−２８およびｉｌ−２９の使用法 |
| US8158129B2 (en) * | 2005-04-06 | 2012-04-17 | Ibc Pharmaceuticals, Inc. | Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo |
| AU2006272937A1 (en) * | 2005-07-20 | 2007-02-01 | Bristol-Myers Squibb Company | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| CA2891974A1 (en) | 2012-11-21 | 2014-05-30 | The Governors Of The University Of Alberta | Immunomodulatory peptides and methods of use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60135393D1 (de) * | 2000-06-30 | 2008-09-25 | Zymogenetics Inc | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 |
| US6822082B2 (en) * | 2000-06-30 | 2004-11-23 | Zymogenetics, Inc. | Polynucleotides for mammalian secreted protein, Z1055G2P |
-
2002
- 2002-05-08 WO PCT/US2002/014587 patent/WO2002092762A2/en not_active Ceased
- 2002-05-08 PL PL02373008A patent/PL373008A1/xx not_active Application Discontinuation
- 2002-05-08 MX MXPA03010181A patent/MXPA03010181A/es unknown
- 2002-05-08 EP EP02741697A patent/EP1412499A4/en not_active Withdrawn
- 2002-05-08 JP JP2002589630A patent/JP2004535795A/ja not_active Withdrawn
- 2002-05-08 CA CA002446180A patent/CA2446180A1/en not_active Abandoned
- 2002-05-08 US US10/142,717 patent/US20030104579A1/en not_active Abandoned
- 2002-05-08 AU AU2002314774A patent/AU2002314774B2/en not_active Ceased
-
2006
- 2006-11-20 US US11/602,056 patent/US20070081973A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004535795A5 (https=) | ||
| US12134656B2 (en) | Dickkopf-1 variant antibodies and methods of use | |
| KR101502179B1 (ko) | 전사 부정확, 검출 및 이의 용도 | |
| JP2014509853A5 (https=) | ||
| JP2005514901A5 (https=) | ||
| JP2004512022A5 (https=) | ||
| JP2002502589A5 (https=) | ||
| JP2008538183A5 (https=) | ||
| JP2008525033A5 (https=) | ||
| JP2006516189A5 (https=) | ||
| JP2005514030A5 (https=) | ||
| WO2016077366A1 (en) | Therapeutic and diagnostic methods for il-33-mediated disorders | |
| WO2015107171A1 (en) | Methods of identifying patients suffering from liver cancer who will most likely benefit from a treatment with an antagonist anti-fgfr4 antibody | |
| PT1481989E (pt) | Antigénios relacionados com a-33 e suas utilizações farmacológicas | |
| JP2004535161A5 (https=) | ||
| JP2005511023A5 (https=) | ||
| EP1944321A2 (en) | Methods and compositions for determining the purity of chemically synthesized nucleic acids | |
| JP2005512558A5 (https=) | ||
| JPH1066585A5 (https=) | ||
| EP4667484A1 (en) | Homodimeric protein combining human il-1r1 with human il-1racp polypeptide fragments and use | |
| JP2004537284A5 (https=) | ||
| CN109486824A (zh) | 一种特异性结合Taq酶的核酸适配体及其筛选方法、应用 | |
| JP2003510078A5 (https=) | ||
| JP2012153664A (ja) | 抗ｉｌ２８ｂ抗体及びこれを用いたｉｌ２８ｂの測定方法 | |
| JP2008507253A5 (https=) |